uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Bioresorbable Vascular Scaffolds in a Real-World Patient Population-Results From a Mid-Term Angiographic Follow-Up
Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.;Klinikum Bayreuth, Dept Cardiol, Bayreuth, Germany.;Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany..
Klinikum Bayreuth, Dept Cardiol, Bayreuth, Germany.;Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany..
Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany..
Univ Heart Ctr Lubeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Lubeck, Germany..
Show others and affiliations
2016 (English)In: Journal of interventional cardiology, ISSN 0896-4327, E-ISSN 1540-8183, Vol. 29, no 4, 341-347 p.Article in journal (Refereed) Published
Abstract [en]

Aim: We aimed to investigate the safety and efficacy of bioresorbable vascular scaffolds (BVS) in daily use in a real-world patient population.

Methods and Results: Between March 2013 and September 2014, 224 patients (233 lesions) were treated with BVS at a tertiary care center. Patients underwent follow-up coronary angiography 3-6 months after implantation. Clinical presentations were stable angina in 101 patients (45.1%), unstable angina in 47 (21.0%), NSTEMI in 38 (17.0%), and STEMI in 38 (17.0%) patients. Twenty-two patients (27 lesions) had chronic total occlusion (CTO). Procedural success was achieved in all patients. Two patients died in the follow-up period due to BVS thrombosis (0.9%). In-hospital death occurred in further 3 patients (1.3%) due to other causes not related to the BVS implantation. Total BVS thrombosis was 3.1% (7 patients) and there was only 1 case of relevant restenosis on angiographic follow-up. The overall incidence of major adverse cardiac events was 11 (4.9%).

Conclusions: Mid-term follow-up after implantation of BVS suggests a satisfactory safety profile and low restenosis rate in routine daily practice involving a large range of complex lesions.

Place, publisher, year, edition, pages
2016. Vol. 29, no 4, 341-347 p.
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:uu:diva-308039DOI: 10.1111/joic.12297ISI: 000385430300003PubMedID: 27329969OAI: oai:DiVA.org:uu-308039DiVA: diva2:1049245
Available from: 2016-11-24 Created: 2016-11-23 Last updated: 2016-11-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wikström, Gerhard
By organisation
Cardiology
In the same journal
Journal of interventional cardiology
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 16 hits
ReferencesLink to record
Permanent link

Direct link